Novel Therapy and Diagnosis of Cervical Cancer Radio Resistance for the Future Development

Chanya Engsiridumrongkul,Lei Chang,Aadil Hameed Shah

DOI: https://doi.org/10.5281/zenodo.5717200

2021-01-01

Abstract:Background and introduction: Cervical cancer (CC) is the world's fourth most common malignancy in women, it is predicted that there will be roughly 798 thousand new cases per year during the next 20 years. In the developing world, to overcome this malignancy the standard treatment for cervical cancer is radiotherapy, either alone or in conjunction with chemotherapy. During their treatment, about 80% of cervical cancer patients got radiation therapy. Radio resistance, on the other hand, reduced overall survival. Method: The method of this study is used to conduct online and a regular exploration of data bank like NCBI, PubMed, Embase, SCI Hub, google scholar, cross ref, and the Cochrane Library, using medical terminology like cellular stress with radioresistence where Radiation-induced damage responses cooperate to cause cancer cell death, but radiotherapy also activates damage-repair and survival signaling in a small percentage of cancer cells, alleviating radiation-induced cytotoxicity, and these activations are responsible for tumor radio-resistance. For diagnosis it is critical to investigate and develop more sensitive and specific DNA methylation techniques in order to improve cervical cancer early detection hypermethylation of SEPT9 has a high sensitivity and specificity.it could also improve cell resistance to ionizing radiation by changing the polarization of tumor-associated macrophages. Conclusion: Traditional tumor therapy such as chemotherapy, targeted therapy, radiotherapy, surgery, and others, have been criticized in recent years for being slow and has limitations with side effects, to overcome these problems nanoparticles have the potential to not only address the inadequacies of traditional cancer diagnosis and treatment, but also to open entirely new avenues and develop cutting-edge technology for tumor detection and treatment. However, most nanoparticle research is conducted in vivo and in vitro, and only a few clinical studies on nanoparticles have been published.